Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. clinical trials

Acquired by Chongqing Zhifei Biological Products Co., Ltd.

The registry lists 48 studies whose lead sponsor is Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 3, 2026.

Studies

Recruiting first, then most recently updated. Showing 48 of 48. All Chongqing Zhifei Biological Products Co., Ltd. studies →

• Clinical Trials of Quadrivalent Influenza VaccineRecruitingNCT06824519Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)Not yet recruitingNCT06025812Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Safety Study of COVID19 Vaccine on the MarketRecruitingNCT05890521Phase 4

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in IndonesiaCompletedNCT07587164Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and AboveCompletedNCT05899179Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• BCG for Therapeutic Use Phase Ⅲ Clinical TrialActive, not recruitingNCT06747455Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• BCG for Therapeutic Use Phase I Clinical TrialCompletedNCT06100653Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase II Clinical Clical of the Pure Protein Derivatives of BCGCompletedNCT06975774Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)Active, not recruitingNCT06524947Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis PatientsActive, not recruitingNCT04538911Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)CompletedNCT04563533Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion ProteinCompletedNCT05746611Phase 4

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)CompletedNCT05574985Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Trial of MicaActive, not recruitingNCT05680415Phase 4

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)CompletedNCT05850507Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split VaccineCompletedNCT05642078Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)SuspendedNCT05284812Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)Active, not recruitingNCT04852068Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)CompletedNCT06078423Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical TrialStatus unknownNCT06043388Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVacCompletedNCT05205096Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic ImmunizationCompletedNCT05198063Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2CompletedNCT05895110Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza VaccineCompletedNCT05107375Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of BCG Vaccine for Intradermal InjectionCompletedNCT04563273Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)CompletedNCT04961359Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)CompletedNCT05109598Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)Status unknownNCT05616754Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic ImmunizationCompletedNCT05198102Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)CompletedNCT04239313Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-driedCompletedNCT03026972Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Status unknownNCT05128643Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase I Clinical Protocol of BCG-PPD in Healthy PeopleCompletedNCT04593771Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorVStatus unknownNCT05205083Phase 1/2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19Status unknownNCT04646590Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)Status unknownNCT05091411Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing ImmunityCompletedNCT05089045Not applicable

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)Status unknownNCT04550351Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase I Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04445194Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04466085Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)CompletedNCT02795260Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent TuberculosisCompletedNCT01979900Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 AllergenCompletedNCT02623556Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for ChildrenCompletedNCT03027154Phase 3

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02336542Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65CompletedNCT02389322Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02329730Phase 2

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group

• Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT01999231Phase 1

  Sponsor listed in the registry: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — acquired company within the Chongqing Zhifei Biological Products Co., Ltd. group